bpc 157 clinical evidence human randomized trial Multifunctionality and Possible Medical Application of the Peptide—Literature and Patent Review What do we know about
Description
Common Side Effects Reported side effects with BPC-157 are generally mild and transient

Phase I human trial of parent molecule (TB-4) showed no serious adverse events Mild injection site reactions possible Same theoretical angiogenesis/tumor concern as BPC-157 Head rush or lightheadedness reported anecdotally at higher doses Can You Stack BPC-157 and TB-500
Always toss any leftover product after four weeks

PMID: 60 GodingJWHowardMC